Provenance Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.22K | Sell |
240
-94
| -28% | -$3.61K | ﹤0.01% | 314 |
|
|
2025
Q1 | $12.9K | Hold |
334
| – | – | ﹤0.01% | 306 |
|
|
2024
Q4 | $11.3K | Hold |
334
| – | – | ﹤0.01% | 307 |
|
|
2024
Q3 | $13.7K | Hold |
334
| – | – | ﹤0.01% | 316 |
|
|
2024
Q2 | $12.9K | Hold |
334
| – | – | ﹤0.01% | 282 |
|
|
2024
Q1 | $14.3K | Hold |
334
| – | – | ﹤0.01% | 296 |
|
|
2023
Q4 | $12.4K | Buy |
334
+94
| +39% | +$3.48K | ﹤0.01% | 300 |
|
|
2023
Q3 | $8.7K | Buy |
+240
| New | +$8.7K | ﹤0.01% | 250 |
|